Tightening US And European Regulations Will Stunt Diagnostic Developments
AN
AnalystLowTarget
Not Invested
Consensus Narrative from 20 Analysts
Published
23 Aug 25
Updated
23 Aug 25
AnalystLowTarget's Fair Value
US$116.83
39.1% overvalued intrinsic discount23 Aug
US$162.47
1Y
37.6%7D
0.8%1Y
37.6%7D
0.8%